Invenomic Capital Management LP Anika Therapeutics, Inc. Transaction History

Invenomic Capital Management LP

  • $1.99 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$18.47 - $23.3 $2.16 Million - $2.72 Million
116,679 Added 124.59%
210,332 $4.77 Million
Q3 2023

Nov 14, 2023
BUY
$16.98 - $26.1 $1.59 Million - $2.44 Million
93,653 New
93,653 $1.74 Million
Q3 2022

Nov 14, 2022
SELL
$21.74 - $24.68 $86,416 - $98,103
-3,975 Reduced 2.75%
140,312 $3.34 Million
Q2 2022

Aug 15, 2022
BUY
$20.4 - $25.53 $2.94 Million - $3.68 Million
144,287 New
144,287 $3.22 Million

Others Institutions Holding ANIK

# of Institutions
118
Shares Held
10.7M
Call Options Held
0
Put Options Held
0
View Full List

About Anika Therapeutics, Inc.

ANIK Quotes by TradingView
  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $145M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email